Dexamphetamine given long-acting to reduce cocaine use
Part of Mental health clinical trials.
This Phase 2 study tests whether a long-acting form of dexamphetamine can reduce cocaine use in people with moderate to severe cocaine use disorder. It also checks safety, including heart and mental health side effects, while you attend study visits regularly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 18 or older.
- You’re currently taking methadone by mouth as part of opioid treatment.
- You’ve been using cocaine regularly in the last month (at least 8 days).
- You usually use cocaine by snorting, inhaling, or injecting (not mainly other routes).
- You want to reduce or stop your cocaine use and can attend the center 2 days each week.
- You can join study visits and tests for the planned 30 weeks and speak enough Dutch to complete assessments.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a medication called pentoxifylline can reduce cocaine use in people who smoke or inject cocaine but aren't ready to stop. You'll receive either pentoxifylline or a placebo to see if it helps control cravings or use.
This study tests whether a non-invasive brain stimulation method called tDCS can help reduce cocaine use. You would receive several sessions of mild electrical current applied to your scalp, which may help control cravings and improve your ability to stay abstinent.
This trial tests whether a combination of ketamine (a medicine that may help the brain change) and neurofeedback training (a brain-exercise technique) can help people with cocaine addiction. The goal is to see if these treatments can improve brain flexibility and reduce cravings.
This study tests a combination of brain stimulation (rTMS) and talk therapy (CBT) to help people reduce cocaine use. It's for adults who want treatment and use cocaine at least once a week.
This early-phase study uses brain imaging to understand how cocaine use disorder affects brain function. It may help researchers learn more about brain pathways involved in craving and treatment targets.
This early-phase study uses a PET brain scan (a special imaging test) to see how the brain responds in people with cocaine use disorder. It aims to better understand brain activity and whether this scan approach could help research or future treatments.
Hear when a new Cocaine Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.